Anebulo Pharmaceuticals

Anebulo was founded with the intention of developing disruptive treatments for substance use disorders, such as cannabinoid intoxication and the broader addiction landscape.

We understand the burden of these diseases and are committed to addressing the unmet medical need in each through evidence-based medicine that drives both clinical and behavioral change period.

Our purpose is to harness our innovative, life-saving therapies to improve the lives of millions of patients and empower those who are struggling with addiction to regain control of their lives.